英: aminoglycoside
関: アミノグリコシド、アミノグリコシド系、アミノ配糖体系、アミノグリコシド系抗生物質、アミノグリコシド系薬、アミノ糖系抗生物質、アミノ配糖体系抗生物質

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. アミノグリコシドaminoglycosides [show details]
… gram-positive infections. In addition, certain aminoglycosides have demonstrated clinically relevant activity against protozoa (paromomycin), Neisseria gonorrhoeae (spectinomycin, not available in the United States) …
2. アミノグリコシド（非経口）の用量および投与dosing and administration of parenteral aminoglycosides [show details]
… information about aminoglycosides is found elsewhere. This topic refers to dosing of aminoglycosides for the treatment of typical bacterial infections. While the pharmacokinetics of plazomicin are generally …
3. 嚢胞性線維腺症：呼吸器症状が急性増悪した場合の治療cystic fibrosis treatment of acute pulmonary exacerbations [show details]
… history of prior aminoglycoside toxicity. The goal is to ensure that the aminoglycoside level remains relatively low for several hours prior to the next dose (ideally ≤0.5 for tobramycin at 18 hours). An …
4. アミノグリコシドによる腎毒性の症状および危険因子manifestations of and risk factors for aminoglycoside nephrotoxicity [show details]
… that toxic aminoglycoside concentrations will develop and persist in the renal cortex. For any given aminoglycoside, a direct relationship exists between serum concentrations of aminoglycosides, renal cortical …
5. アミノグリコシドの腎毒性および聴覚毒性の病因および予防pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity [show details]
… large dose of aminoglycoside once a day is as effective an antimicrobial regimen and less nephrotoxic than giving aminoglycosides in the conventional, divided-dose regimen . Aminoglycosides may also have …